Literature DB >> 7773586

Intensive care and oncology.

J P Sculier1.   

Abstract

Intensive care is increasingly used in the management of cancer patients. The main reasons for admitting a cancer patient to an intensive-care unit are postoperative recovery, critical complications of the cancer disease and its treatment, the administration and monitoring of intensive anticancer treatment, and acute disease unrelated to cancer or its treatment. The present review is focused on the prognosis of critically ill cancer patients, on the description of the types of complications requiring intensive care, on specific aspects of the application of critical-care techniques in cancer patients, on ethical considerations and on ICU organization in the context of oncology.

Entities:  

Mesh:

Year:  1995        PMID: 7773586     DOI: 10.1007/bf00365848

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  95 in total

Review 1.  The cardiotoxicity of chemotherapeutic drugs.

Authors:  A Allen
Journal:  Semin Oncol       Date:  1992-10       Impact factor: 4.929

2.  An ethical look at intensive care for patients with malignancies.

Authors:  J C Chevrolet; P Jolliet
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

3.  Is intensive care justified for patients with haematological malignancies?

Authors:  F Brunet; J J Lanore; J F Dhainaut; F Dreyfus; J F Vaxelaire; S Nouira; T Giraud; A Armaganidis; J F Monsallier
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

4.  Decisions about resuscitation: inequities among patients with different diseases but similar prognoses.

Authors:  R M Wachter; J M Luce; N Hearst; B Lo
Journal:  Ann Intern Med       Date:  1989-09-15       Impact factor: 25.391

5.  Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy.

Authors:  D P Schuster; J M Marion
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

Review 6.  Superior vena cava obstruction syndrome: recommendations for management.

Authors:  J P Sculier; R Feld
Journal:  Cancer Treat Rev       Date:  1985-09       Impact factor: 12.111

7.  Cardiopulmonary resuscitation and the patient with cancer.

Authors:  C E Vitelli; K Cooper; A Rogatko; M F Brennan
Journal:  J Clin Oncol       Date:  1991-01       Impact factor: 44.544

8.  Intensive therapy for life-threatening medical complications of haematological malignancy.

Authors:  A R Lloyd-Thomas; H S Dhaliwal; T A Lister; C J Hinds
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

9.  High-dose ifosfamide is associated with severe, reversible cardiac dysfunction.

Authors:  Z M Quezado; W H Wilson; R E Cunnion; M M Parker; D Reda; G Bryant; F P Ognibene
Journal:  Ann Intern Med       Date:  1993-01-01       Impact factor: 25.391

10.  Outcome of children with hematologic malignancy who are admitted to an intensive care unit.

Authors:  W Butt; G Barker; C Walker; J Gillis; H Kilham; M Stevens
Journal:  Crit Care Med       Date:  1988-08       Impact factor: 7.598

View more
  5 in total

1.  Rate and patterns of ICU admission among colorectal cancer patients: a single-center experience.

Authors:  M F Camus; L Ameye; T Berghmans; M Paesmans; J P Sculier; A P Meert
Journal:  Support Care Cancer       Date:  2014-12-04       Impact factor: 3.603

2.  Leucopenia is an independent predictor in cancer patients requiring invasive mechanical ventilation: a prognostic factor analysis in a series of 168 patients.

Authors:  F Vallot; M Paesmans; T Berghmans; J P Sculier
Journal:  Support Care Cancer       Date:  2003-01-22       Impact factor: 3.603

3.  Predictors associated with planned and unplanned admission to intensive care units after colorectal cancer surgery: a retrospective study.

Authors:  Xiao-Yu Liu; Chao Yuan; Bing Kang; Yu-Xi Cheng; Wei Tao; Bin Zhang; Zheng-Qiang Wei; Dong Peng
Journal:  Support Care Cancer       Date:  2022-02-28       Impact factor: 3.603

4.  Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study.

Authors:  Márcio Soares; Flávia Fontes; Joana Dantas; Daniela Gadelha; Paloma Cariello; Flávia Nardes; César Amorim; Luisa Toscano; José R Rocco
Journal:  Crit Care       Date:  2004-05-24       Impact factor: 9.097

5.  Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  G Maschmeyer; J Carratalà; D Buchheidt; A Hamprecht; C P Heussel; C Kahl; J Lorenz; S Neumann; C Rieger; M Ruhnke; H Salwender; M Schmidt-Hieber; E Azoulay
Journal:  Ann Oncol       Date:  2014-05-15       Impact factor: 32.976

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.